Following TME Pharma?
Get the free weekly contract digest
The latest new contracts, like TME Pharma’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
TME Pharma Announces Partnership with Aimed Analytics for AI-Driven Drug Discovery
Jan 29, 2025•over 1 year ago
Contract Type
partnership
Description
TME Pharma N.V. has announced a collaboration with aimed analytics, a cutting-edge medical data analytics company, to leverage artificial intelligence (AI) for creating new and improved drug candidates without the need for time and resource-intensive laboratory testing. This partnership aims to accelerate the discovery of more effective treatments and potentially lead to breakthrough therapies for patients in need.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months